Stephen Tsang: Difference between revisions
m →Career |
m →Career |
||
Line 51: | Line 51: | ||
He is also a standing member of the Pathophysiology of Eye Disease - 2 study section until 2026 <ref>{{Cite web|url=https://public.era.nih.gov/pubroster/roster.era?CID=105273|title= Pathophysiology of Eye Disease - 2 Study Section}}</ref> and a member of the Alcon Research Institute Grants Review Committee.<ref>{{Cite web|url= https://www.alcon.com/sites/g/files/rbvwei496/files/2022-06/2022-2023_ARI_Committee_Members.pdf|title=·2022-2023 ARI Committee Members}}</ref> |
He is also a standing member of the Pathophysiology of Eye Disease - 2 study section until 2026 <ref>{{Cite web|url=https://public.era.nih.gov/pubroster/roster.era?CID=105273|title= Pathophysiology of Eye Disease - 2 Study Section}}</ref> and a member of the Alcon Research Institute Grants Review Committee.<ref>{{Cite web|url= https://www.alcon.com/sites/g/files/rbvwei496/files/2022-06/2022-2023_ARI_Committee_Members.pdf|title=·2022-2023 ARI Committee Members}}</ref> |
||
Tsang is the editor of three books on [[regenerative medicine]] and [[precision medicine]].<ref>{{Cite book|url=https://www.springer.com/us/book/9783319639031|title=Precision Medicine, CRISPR, and Genome Engineering – Moving from Association to Biology and Therapeutics {{!}} Stephen Tsang {{!}} Springer|language=en}}</ref><ref>{{Cite news|date=2017-12-05|title=Recent book publication edited by Dr. Stephen Tsang|language=en|work=Columbia Stem Cell Initiative – CSCI|url=https://www.stemcell.columbia.edu/recent-book-publication-edited-dr-stephen-tsang|access-date=2018-07-11}}</ref><ref>{{Cite book|url=https://www.springer.com/la/book/9781461454922|title=Stem Cell Biology and Regenerative Medicine in Ophthalmology {{!}} Stephen Tsang {{!}} Springer|language=en}}</ref><ref>{{Cite book|url= https://www.elsevier.com/books/crispr-genome-surgery-in-stem-cells-and-disease-tissues/tsang/978-0-12-817876-8 |title= CRISPR Genome Surgery in Stem Cells and Disease Tissues {{!}} Stephen Tsang {{!}} Elsevier|language=en}}</ref> He has authored over 280 peer reviewed articles, including articles published in ''[[Science (journal)|Science]]'', ''[[Journal of Clinical Investigation]]'', and the ''[[New England Journal of Medicine]]''.<ref>{{Cite web|last=pubmeddev|title=tsang sh – PubMed – NCBI|url=https://pubmed.ncbi.nlm.nih.gov/?term=tsang+sh|access-date=2018-07-13|website=www.ncbi.nlm.nih.gov|language=en}}</ref><ref>{{Cite web|url=https://www.nejm.org/doi/10.1056/NEJMicm1913388|title= Oh, J. K., & Tsang, S. H. (2020). Stargardt Juvenile Macular Degeneration. New England Journal of Medicine, 382(24), 2353–2353. Doi:10.1056/nejmicm1913388 }}</ref> |
Tsang is the editor of three books on [[regenerative medicine]] and [[precision medicine]].<ref>{{Cite book|url=https://www.springer.com/us/book/9783319639031|title=Precision Medicine, CRISPR, and Genome Engineering – Moving from Association to Biology and Therapeutics {{!}} Stephen Tsang {{!}} Springer|language=en}}</ref><ref>{{Cite news|date=2017-12-05|title=Recent book publication edited by Dr. Stephen Tsang|language=en|work=Columbia Stem Cell Initiative – CSCI|url=https://www.stemcell.columbia.edu/recent-book-publication-edited-dr-stephen-tsang|access-date=2018-07-11}}</ref><ref>{{Cite book|url=https://www.springer.com/la/book/9781461454922|title=Stem Cell Biology and Regenerative Medicine in Ophthalmology {{!}} Stephen Tsang {{!}} Springer|language=en}}</ref><ref>{{Cite book|url= https://www.elsevier.com/books/crispr-genome-surgery-in-stem-cells-and-disease-tissues/tsang/978-0-12-817876-8 |title= CRISPR Genome Surgery in Stem Cells and Disease Tissues {{!}} Stephen Tsang {{!}} Elsevier|language=en}}</ref> He also edited a book on inherited retinal diseases.<ref>{{Cite book|url= https://link.springer.com/book/10.1007/978-3-319-95046-4#book-header|title= Atlas of Inherited Retinal Diseases{{!}}Stephan Tsang and Tarun Sharma{{!}}Springer}}</ref>He has authored over 280 peer reviewed articles, including articles published in ''[[Science (journal)|Science]]'', ''[[Journal of Clinical Investigation]]'', and the ''[[New England Journal of Medicine]]''.<ref>{{Cite web|last=pubmeddev|title=tsang sh – PubMed – NCBI|url=https://pubmed.ncbi.nlm.nih.gov/?term=tsang+sh|access-date=2018-07-13|website=www.ncbi.nlm.nih.gov|language=en}}</ref><ref>{{Cite web|url=https://www.nejm.org/doi/10.1056/NEJMicm1913388|title= Oh, J. K., & Tsang, S. H. (2020). Stargardt Juvenile Macular Degeneration. New England Journal of Medicine, 382(24), 2353–2353. Doi:10.1056/nejmicm1913388 }}</ref> |
||
== Education == |
== Education == |
Revision as of 14:25, 3 August 2022
Stephen H. Tsang | |
---|---|
曾慶霖 | |
Born | British Hong Kong |
Education | Johns Hopkins University (B.S.), Columbia College of Physicians and Surgeons (M.D.–Ph.D.) |
Scientific career | |
Fields | ophthalmology, genetics |
Institutions | Columbia University Irving Medical Center |
Stephen H. Tsang (Chinese: 曾慶霖; Pinyin: Zeng Qing-Lin) is an American ophthalmologist and geneticist. He is currently a Professor of Ophthalmology, and Pathology and Cell Biology at Columbia University Irving Medical Center in New York.[1]
Career
Professor Tsang studies metabolic signaling in retinal diseases, as well as gene therapy and stem cell therapy to treat such diseases.[2][3][4][5] In 2010, Tsang led an international research team that used embryonic stem cells of mice to replace diseased retinal cells in mice with retinitis pigmentosa to restore sight.[6] In 2012, Tsang produced long term visual improvement in retinitis pigmentosa mouse models in two experiments, one using induced pluripotent stem cells and the other gene therapy.[7] In 2015, Tsang was among the leaders of a team which discovered a gene mutation that can cause achromatopsia.[1] In 2016, Tsang's team, in partnership with University of Iowa scientists, used the genome editing tool called CRISPR to repair a mutation that causes retinitis pigmentosa in patient derived stem cells.[8][9][10] In 2018, Tsang and his team created a new technique for CRISPR, restoring function in the retina of mice affected by retinitis pigmentosa.[3][11][12]
Tsang is a member of the Scientific Advisory Panel of Research to Prevent Blindness effective until 2029.[13] He is also a standing member of the Pathophysiology of Eye Disease - 2 study section until 2026 [14] and a member of the Alcon Research Institute Grants Review Committee.[15]
Tsang is the editor of three books on regenerative medicine and precision medicine.[16][17][18][19] He also edited a book on inherited retinal diseases.[20]He has authored over 280 peer reviewed articles, including articles published in Science, Journal of Clinical Investigation, and the New England Journal of Medicine.[21][22]
Education
Tsang was born in British Hong Kong's Evangel Hospital 播道醫院. He went to St. Teresa's Kindergarten and St. Teresa's Primary School (STS, 九龍聖德肋撒英文學校) , then onto La Salle College, all in Kowloon, Hong Kong. He immigrated to the United States after La Salle College, graduating from Johns Hopkins University.[23]
During college, Tsang trained in medical genetics under Professor Victor A. McKusick.[24] He obtained an M.D.-Ph.D. from the NIH-National Institute of General Medical Sciences Medical Scientist Training Program at Columbia University.[24] Tsang did his residency at Jules Stein Eye Institute/UCLA, and then he studied with Professors Alan C. Bird and Graham E. Holder, researching how to improve care of people suffering from macular degeneration.[1]
References
- ^ a b c "Stephen H. Tsang, MD, PhD". Pathology. 2017-06-21. Retrieved 2018-07-11.
- ^ "Scientists foresee fixes even for complicated forms of blindness". NBC News. Retrieved 2018-07-11.
- ^ a b "Genome Surgery for Eye Disease Moves Closer to Reality – American Academy of Ophthalmology". www.aao.org. Retrieved 2018-07-11.
- ^ "Stephen Tsang | NYSTEM". stemcell.ny.gov. Retrieved 2018-07-11.
- ^ [CUMC press office] (1 June 2015). New Color Blindness Cause Identified Finding Suggests Potential Therapeutic Targets. States News Service. Accessed November 2015. (subscription required)
- ^ "Columbia University Medical Center Press Release". www.cumc.columbia.edu. Retrieved 2018-07-11.
- ^ "Two Treatments for Retinitis Pigmentosa Move Closer to Clinical Trials – Columbia University Medical Center". Columbia University Medical Center. 2012-12-20. Retrieved 2018-07-11.
- ^ "Combination of Stem Cells and Gene Modifying Tools Provide Path to Vision Repair | NYSTEM". stemcell.ny.gov. Retrieved 2018-07-11.
- ^ Mullin, Emily. "CRISPR Used To Repair Blindness-Causing Gene Defect". Forbes. Retrieved 2018-07-19.
- ^ ""Genome Surgery" Edits out Progressive Blindness in Mice". Genomics Research from Technology Networks. Retrieved 2019-06-18.
- ^ "Columbia University Medical Center Press Release". www.cumc.columbia.edu. Retrieved 2018-07-11.
- ^ "Synthego | Full Stack Genome Engineering". www.synthego.com. Retrieved 2019-06-19.
- ^ "Research to Prevent Blindness: Scientific Advisory Panel". www.rpbusa.org/rpb/.
- ^ "Pathophysiology of Eye Disease - 2 Study Section".
- ^ "·2022-2023 ARI Committee Members" (PDF).
- ^ Precision Medicine, CRISPR, and Genome Engineering – Moving from Association to Biology and Therapeutics | Stephen Tsang | Springer.
- ^ "Recent book publication edited by Dr. Stephen Tsang". Columbia Stem Cell Initiative – CSCI. 2017-12-05. Retrieved 2018-07-11.
- ^ Stem Cell Biology and Regenerative Medicine in Ophthalmology | Stephen Tsang | Springer.
- ^ CRISPR Genome Surgery in Stem Cells and Disease Tissues | Stephen Tsang | Elsevier.
- ^ Atlas of Inherited Retinal Diseases|Stephan Tsang and Tarun Sharma|Springer.
- ^ pubmeddev. "tsang sh – PubMed – NCBI". www.ncbi.nlm.nih.gov. Retrieved 2018-07-13.
- ^ "Oh, J. K., & Tsang, S. H. (2020). Stargardt Juvenile Macular Degeneration. New England Journal of Medicine, 382(24), 2353–2353. Doi:10.1056/nejmicm1913388".
- ^ "Stephen H. Tsang, MD, PhD". Institute of Genomic Medicine. Retrieved 2018-07-11.
- ^ a b "Columbia Ophthalmology". www.columbiaeye.org. Retrieved 2018-07-11.